SELECTIVE SENSITIVITY OF CHRONIC MYELOGENOUS LEUKEMIA-CELL POPULATIONS TO ALKYL-LYSOPHOSPHOLIPIDS
- 1 January 1979
- journal article
- research article
- Vol. 54 (2) , 519-523
Abstract
To evaluate the specificity of alkyllysophospholipid-induced cell destruction, peripheral blood leukocytes from chronic myelogenous leukemia (CML) patients in chronic phase of the disease as well as in blastic crisis were separated by density centrifugation. These subpopulations, enriched for the different maturation stages, were tested for their sensitivity to alkyl-lysophospholipids. Myelocytes in chronic phase CML are resistant, but blast cells from both clinical stages as well as maturational defective myelocytes from blastic crisis CML are highly sensitive to these antimetabolites. In contrast to chronic phase CML myelocytes, these sensitive cells show a high lysophospholipid adsorption rate and lack an O-alkyl-cleavage enzyme.This publication has 5 references indexed in Scilit:
- Evidence for a Proliferative Advantage of Human Leukemia Colony-Forming Cells In Vitro 23JNCI Journal of the National Cancer Institute, 1978
- SELECTIVE DESTRUCTION OF HUMAN LEUKEMIC-CELLS BY ALKYL-LYSOPHOSPHOLIPIDS1978
- Synthesis and Release of Thymidine by MacrophagesThe Journal of Immunology, 1977
- Chronic myelocytic leukemia: Clonal origin in a stem cell common to the granulocyte, erythrocyte, platelet and monocyte/macrophageThe American Journal of Medicine, 1977
- THE METABOLISM AND FATE OF TRITIATED THYMIDINE IN MAN *†Journal of Clinical Investigation, 1960